Rhythm Pharmaceuticals (RYTM) Earnings
|
Expand Research on RYTM
| Next EPS Date | 8/4/26 | EPS Growth Rate | -8.0% |
|---|---|---|---|
| Average EPS % Beat Rate | -4.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -4.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/4/26  |
Q226 | N/A | -$0.81 | N/A | N/A | $67.53M | N/A | N/A | N/A | ||
| 5/5/26 | Q126 | -$0.83 | -$0.83 | $0.00 | $60.11M | $55.62M | N/A |  | | Details | |
| 2/26/26 | Q425 | -$0.73 | -$0.82 | +$0.09 | $57.3M | $55.24M | N/A | | | Details | |
| 11/4/25 | Q325 | -$0.82 | -$0.71 | -$0.11 | $51.3M | $51.02M | N/A | | | Details | |
| 8/5/25 | Q225 | -$0.75 | -$0.67 | -$0.08 | N/A | $43.75M | N/A | | | Details | |
| 5/7/25 |
Q125 | N/A | -$0.67 | N/A | N/A | $40.7M | N/A | N/A | N/A | ||
| 2/26/25 | Q424 | -$0.72 | -$0.74 | +$0.02 | $41.83M | $36.04M | N/A | | | Details | |
| 11/5/24 | Q324 | -$0.73 | -$0.80 | +$0.07 | $33.25M | $32.42M | N/A | | | Details |
